Skip to main content
Erschienen in:

27.05.2020 | Research Article

Positioning error analysis of the fraxion localization system in the intracranial stereotactic radiotherapy of tumors

verfasst von: D.-C. He, Z.-J. Zhu, X.-Y. Zhang, Y. Zhang, J. Hong, T.-T. Shi, C.-H. Yu, J.-H. Han

Erschienen in: Clinical and Translational Oncology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate positioning error analysis of the Fraxion localization system in the intracranial stereotactic radiotherapy of tumors.

Methods

64 patients were divided into two groups: a control group (36 patients with the standard thermoplastic mask) and a model group (28 patients with the Fraxion localization system). 3D images of the treated position were obtained by cone-beam computed tomography (CBCT). Positioning errors were obtained by, respectively, registering these two sets of CBCT images to planning CT images, using a 6°-freedom robotic patient positioning system (HexaPOD Evo RT System). The changes in positioning errors with the Fraxion localization system and with the standard thermoplastic mask were analyzed.

Results

CBCT scan results of the model group showed that the mean of linear error of three directions [superior-inferior (SI), lateral (LAT), and anterior–posterior (AP)] was 0.710 ± 0.676 mm, 0.817 ± 0.687 mm, and 0.710 ± 0.685 mm, respectively. The corresponding PTV was 1.23 mm, 1.26 mm, and 1.36 mm. The differences between the 3D images and the planned CT images were significant (p < 0.001).

Conclusion

The Fraxion radiotherapy system can not only improve the positioning accuracy and reduce positioning errors but also narrow the PTV margin and reduce the radiated volume of normal tissue.
Literatur
1.
Zurück zum Zitat Jeong WJ, Park JH, Lee EJ, Kim JH, Kim CJ, Cho YH. Efficacy and safety of fractionated stereotactic radiosurgery for large brain metastases. J Korean Neurosurg Soc. 2015;58:217–24.CrossRef Jeong WJ, Park JH, Lee EJ, Kim JH, Kim CJ, Cho YH. Efficacy and safety of fractionated stereotactic radiosurgery for large brain metastases. J Korean Neurosurg Soc. 2015;58:217–24.CrossRef
2.
Zurück zum Zitat Boman E, Kapanen M, Laaksomaa M, Mäenpää H, Hyödynmaa S, Kellokumpu-Lehtinen PL. Treatment accuracy without rotational setup corrections in intracranial SRT. J Appl Clin Med Phys. 2016;17(4):86–94.CrossRef Boman E, Kapanen M, Laaksomaa M, Mäenpää H, Hyödynmaa S, Kellokumpu-Lehtinen PL. Treatment accuracy without rotational setup corrections in intracranial SRT. J Appl Clin Med Phys. 2016;17(4):86–94.CrossRef
3.
Zurück zum Zitat Jin H, Keeling VP, Ali I, Ahmad S. Dosimetric effects of positioning shifts using 6D-frameless stereotactic Brainlab system in hypofractionated intracranial radiotherapy. J Appl Clin Med Phys. 2016;17(1):102–11.CrossRef Jin H, Keeling VP, Ali I, Ahmad S. Dosimetric effects of positioning shifts using 6D-frameless stereotactic Brainlab system in hypofractionated intracranial radiotherapy. J Appl Clin Med Phys. 2016;17(1):102–11.CrossRef
4.
Zurück zum Zitat Seravalli E, van Haaren PM, van der Toorn PP, Hurkmans CW. A comprehensive evaluation of treatment accuracy, including end-to-end tests and clinical data, applied to intracranial stereotactic radiotherapy. Radiother Oncol. 2015;116(1):131–8.CrossRef Seravalli E, van Haaren PM, van der Toorn PP, Hurkmans CW. A comprehensive evaluation of treatment accuracy, including end-to-end tests and clinical data, applied to intracranial stereotactic radiotherapy. Radiother Oncol. 2015;116(1):131–8.CrossRef
5.
Zurück zum Zitat Tanaka Y, Oita M, Inomata S, Fuse T, Akino Y, Shimomura K. Impact of patient positioning uncertainty in noncoplanar intracranial stereotactic radiotherapy. J Appl Clin Med Phys. 2020;21(2):89–97.CrossRef Tanaka Y, Oita M, Inomata S, Fuse T, Akino Y, Shimomura K. Impact of patient positioning uncertainty in noncoplanar intracranial stereotactic radiotherapy. J Appl Clin Med Phys. 2020;21(2):89–97.CrossRef
6.
Zurück zum Zitat Russo M, Owen R, Bernard A, Moutrie V, Foote M. Evaluation of accuracy and reproducibility of a relocatable maxillary fixation system for fractionated intracranial stereotactic radiation therapy. J Med Radiat Sci. 2016;63(1):41–7.CrossRef Russo M, Owen R, Bernard A, Moutrie V, Foote M. Evaluation of accuracy and reproducibility of a relocatable maxillary fixation system for fractionated intracranial stereotactic radiation therapy. J Med Radiat Sci. 2016;63(1):41–7.CrossRef
7.
Zurück zum Zitat Morimoto CY, Mayer MN, Sidhu N, Bloomfield R, Waldner CL. Residual setup error in the canine intracranial region after megavoltage, kilovoltage, or cone-beam computed tomographic image guidance for radiation therapy. Vet Comp Oncol. 2020;18(2):199–205.CrossRef Morimoto CY, Mayer MN, Sidhu N, Bloomfield R, Waldner CL. Residual setup error in the canine intracranial region after megavoltage, kilovoltage, or cone-beam computed tomographic image guidance for radiation therapy. Vet Comp Oncol. 2020;18(2):199–205.CrossRef
8.
Zurück zum Zitat Berndt A, van Prooijen M, Guillot M. COMP report: CPQR technical quality control guidelines for Gamma Knife radiosurgery. J Appl Clin Med Phys. 2018;19(5):365–7.CrossRef Berndt A, van Prooijen M, Guillot M. COMP report: CPQR technical quality control guidelines for Gamma Knife radiosurgery. J Appl Clin Med Phys. 2018;19(5):365–7.CrossRef
9.
Zurück zum Zitat Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand. 1951;102:312–9. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand. 1951;102:312–9.
10.
Zurück zum Zitat Ruschin M, Nayebi N, Carlsson P, Brown K, Tamerou M, Li W, Laperriere N, Sahgal A, Cho YB, Ménard C, Jaffray D. Performance of a novel repositioning head frame for gamma knife perfexion and image-guided linac-based intracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78:306–13.CrossRef Ruschin M, Nayebi N, Carlsson P, Brown K, Tamerou M, Li W, Laperriere N, Sahgal A, Cho YB, Ménard C, Jaffray D. Performance of a novel repositioning head frame for gamma knife perfexion and image-guided linac-based intracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78:306–13.CrossRef
11.
Zurück zum Zitat Sayer FT, Sherman JH, Yen CP, Schlesinger DJ, Kersh R, Sheehan JP. Initial experience with the eXtend System: a relocatable frame system for multiple-session Gamma Knife radiosurgery. World Neurosurg. 2011;75:665–72.CrossRef Sayer FT, Sherman JH, Yen CP, Schlesinger DJ, Kersh R, Sheehan JP. Initial experience with the eXtend System: a relocatable frame system for multiple-session Gamma Knife radiosurgery. World Neurosurg. 2011;75:665–72.CrossRef
12.
Zurück zum Zitat van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14(1):52–64.CrossRef van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14(1):52–64.CrossRef
13.
Zurück zum Zitat Zollner B, Heinz C, Pitzler S, Manapov F, Kantz S, Rottler MC, Niyazi M, Ganswindt U, Belka C, Ballhausen H. Stereoscopic X-ray imaging, cone beam CT, and couch positioning in stereotactic radiotherapy of intracranial tumors: preliminary results from a cross-modality pilot installation. Radiat Oncol. 2016;11(1):158.CrossRef Zollner B, Heinz C, Pitzler S, Manapov F, Kantz S, Rottler MC, Niyazi M, Ganswindt U, Belka C, Ballhausen H. Stereoscopic X-ray imaging, cone beam CT, and couch positioning in stereotactic radiotherapy of intracranial tumors: preliminary results from a cross-modality pilot installation. Radiat Oncol. 2016;11(1):158.CrossRef
14.
Zurück zum Zitat Wang ZY, Zeng ZL, Tan JW. Electron portal imaging device for the correction of set-up error in intensity-modulated radiotherapy for nasopharyngeal carcinoma and its application. Chin J Med Phys. 2017;34(9):887–92. Wang ZY, Zeng ZL, Tan JW. Electron portal imaging device for the correction of set-up error in intensity-modulated radiotherapy for nasopharyngeal carcinoma and its application. Chin J Med Phys. 2017;34(9):887–92.
15.
Zurück zum Zitat Astreinidou E, Bel A, Raaijmakers CP, Terhaard CH, Lagendijk JJ. Adequate margins for random setup uncertainties in head-and-neck IMRT. Int J Radiat Oncol Biol Phys. 2005;61(3):938–44.CrossRef Astreinidou E, Bel A, Raaijmakers CP, Terhaard CH, Lagendijk JJ. Adequate margins for random setup uncertainties in head-and-neck IMRT. Int J Radiat Oncol Biol Phys. 2005;61(3):938–44.CrossRef
16.
Zurück zum Zitat Russo M, Owen R, Bernard A, Moutrie V, Foote M. Evaluation of accuracy and reproducibility of a relocatable maxillary fixation system for fractionated intracranial stereotactic radiation therapy. J Med Radiat Sci. 2016;63:41–7.CrossRef Russo M, Owen R, Bernard A, Moutrie V, Foote M. Evaluation of accuracy and reproducibility of a relocatable maxillary fixation system for fractionated intracranial stereotactic radiation therapy. J Med Radiat Sci. 2016;63:41–7.CrossRef
Metadaten
Titel
Positioning error analysis of the fraxion localization system in the intracranial stereotactic radiotherapy of tumors
verfasst von
D.-C. He
Z.-J. Zhu
X.-Y. Zhang
Y. Zhang
J. Hong
T.-T. Shi
C.-H. Yu
J.-H. Han
Publikationsdatum
27.05.2020
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 1/2021
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-020-02382-y

Neu im Fachgebiet Onkologie

Genügt die biparametrische MRT für die Prostatadiagnostik?

Die multiparametrische Magnetresonanztomografie hat einen festen Platz im Screening auf klinisch signifikante Prostatakarzinome. Ob auch ein biparametrisches Vorgehen ausreicht, ist in einer Metaanalyse untersucht worden.

Metastasiertes CRC: besser Checkpointhemmer im Doppelpack!

Die Kombination von Nivolumab plus Ipilimumab ist beim metastasierten Kolorektalkarzinom mit MSI-H- oder dMMR klar im Vorteil gegenüber einer Nivolumab-Monotherapie: Das Progressionsrisiko war damit in einer Phase-3-Studie um 38% reduziert.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.